↓ Skip to main content

Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients

Overview of attention for article published in Molecular Neurodegeneration, January 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
2 news outlets
twitter
16 X users
wikipedia
1 Wikipedia page

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients
Published in
Molecular Neurodegeneration, January 2022
DOI 10.1186/s13024-021-00511-x
Pubmed ID
Authors

A. Joseph Bloom, Xianrong Mao, Amy Strickland, Yo Sasaki, Jeffrey Milbrandt, Aaron DiAntonio

X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 56 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 14%
Student > Ph. D. Student 7 13%
Student > Doctoral Student 3 5%
Other 3 5%
Student > Bachelor 2 4%
Other 6 11%
Unknown 27 48%
Readers by discipline Count As %
Neuroscience 10 18%
Biochemistry, Genetics and Molecular Biology 8 14%
Medicine and Dentistry 3 5%
Agricultural and Biological Sciences 3 5%
Business, Management and Accounting 1 2%
Other 3 5%
Unknown 28 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 March 2022.
All research outputs
#1,319,700
of 23,339,727 outputs
Outputs from Molecular Neurodegeneration
#87
of 864 outputs
Outputs of similar age
#33,599
of 509,232 outputs
Outputs of similar age from Molecular Neurodegeneration
#4
of 22 outputs
Altmetric has tracked 23,339,727 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 864 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.5. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 509,232 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.